Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer
European Commission and MHRA approves transfer of marketing...
Read More
Oasmia announces transfer of Nordic commercialization rights for Apealea® (Paclitaxel Micellar) to Inceptua
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Helping get orphan drugs to patients quicker
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Commercialize and partner successfully in Europe and the Middle East
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More